GENDER PECULIARITIES OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH MYOCARDIAL INFARCTION UNDERGOING TRANSCUTANEOUS CORONARY INTERVENTION

O M Lapin

Perm Medical Journal ›› 2015, Vol. 32 ›› Issue (4) : 6 -12.

PDF
Perm Medical Journal ›› 2015, Vol. 32 ›› Issue (4) :6 -12. DOI: 10.17816/pmj3246-12
Articles
research-article

GENDER PECULIARITIES OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH MYOCARDIAL INFARCTION UNDERGOING TRANSCUTANEOUS CORONARY INTERVENTION

Author information +
History +
PDF

Abstract

Aim. To ground the individual gender approach to antithrombotic therapy in patients with myocardial infarction undergoing transcutaneous coronary intervention (TCI). Materials and methods. Seventy patients with reliable prevalence of subjects belonging to the senior age categories among women ( n = 30) 71,5 ± 9,8 versus 62,6 ± 13,7 among men ( n = 39) ( p = 0,003) were examined. Results. Combination of such factors as male sex and senior age was revealed to determine a high risk for hemorrhagic complications (CRUSADE) in women as compared to men - 10,0 ± 3,4 versus 6,6 ± 3,4 scores ( p = 0,0001). Among the treated patients, there were no repeated ischemic events, stent thromboses, mild and severe hemorrhagic complications. Taking into account a short period of semiejection and high safety profile of bivalirudin, its administration and inclusion into antithrombotic therapy for patients with elevation of ST segment in the frame of pharmacoinvasive strategy (combination of prehospital thrombolytic therapy and TCI) is most grounded among females. Conclusions. This variant of therapy permits to minimize the risk for development of the postoperative and hemorrhagic complications among women with myocardial infarction.

Keywords

Myocardial infarction / gender peculiarities / antithrombotic therapy / bivalirudin

Cite this article

Download citation ▾
O M Lapin. GENDER PECULIARITIES OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH MYOCARDIAL INFARCTION UNDERGOING TRANSCUTANEOUS CORONARY INTERVENTION. Perm Medical Journal, 2015, 32(4): 6-12 DOI:10.17816/pmj3246-12

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Совет экспертов. Текущая позиция по бивалирудину. Российский кардиологический журнал 2015; 2 (118): 100-102.

[2]

Шамес А. Б. Ишемическая болезнь сердца у женщин. М.: БИНОМ 2013; 178.

[3]

Bucholz E. M., Butala N. M., Rathore S. S., Dreyer R. P., Lansky A. J., Krumholz H. M. Sex differences in long-term mortality after myocardial infarction: a systematic review. Circulation 2014; 130 (9): 757-767.

[4]

ESC/EACTS Guidelines on myocardial revascularization. Heart Journal Advance, published August 29, 2014, available at: http://eurheartj.oxfordjournals.org/content/ehj/35/37/2541.full.pdf.

[5]

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal 2011; 32: 2999-3054.

[6]

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal 2012; 33: 2569-2619.

[7]

Hemigway H., Langenberg C., Damant J. Prevalence of angina in woman versus men: a systematic review and meta-analysis international variation across 31 countries. Circulation 2008; 117: 1526-1536.

RIGHTS & PERMISSIONS

Lapin O.M.

AI Summary AI Mindmap
PDF

94

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/